Literature DB >> 8741098

Histochemical demonstration of acetylcholinesterase activity in human Meibomian glands.

M T Perra1, A Serra, P Sirigu, F Turno.   

Abstract

The distribution of acetylcholinesterase activity in human Meibomian glands was evaluated using enzyme-histochemical methods. The butyrylcholinesterase (BuChE) inhibitor, tetraisopropyl pyrophosphoramide (iso-OMPA), was used to localize acetylcholinesterase (AChE) activity, the AChE inhibitor, 1,5-bis (4-allyldimethylammoniumphenyl) pentan-3-one dibromide (BW284c51), was used to localize BuChE activity, and eserine was used to inhibit all cholinesterase activity in control incubations; the appropriate specific inhibitors for competing enzymic activities were added to the incubation medium. At the light microscopic level, acetylcholinesterase reaction product appeared as cytoplasmic brown deposits, often crystalline. A very dense accumulation of AChE-positive nerve fibers was seen in the form of a network around the acinar and the ductal tissue of the glands. No discrete nerve endings were observed, whereas a strong reaction was elicited in some fibers in close association with blood vessels. These observations suggest that the cholinergic system is involved in the regulation of the Meibomian glands secretory function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8741098

Source DB:  PubMed          Journal:  Eur J Histochem        ISSN: 1121-760X            Impact factor:   3.188


  10 in total

1.  Botulinum toxin A injection for primary and recurrent chalazia.

Authors:  Tamara Knezevic; Renata Ivekovic; Jasna Pavicic Astalos; Katia Novak Laus; Zdravko Mandic; Aljosa Matejcic
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-11       Impact factor: 3.117

2.  Meibography: A review of techniques and technologies.

Authors:  Ryan J Wise; Rachel K Sobel; Richard C Allen
Journal:  Saudi J Ophthalmol       Date:  2012-10

Review 3.  [Meibomian glands. Part I: anatomy, embryology and histology of the Meibomian glands].

Authors:  N Knop; E Knop
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

Review 4.  The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland.

Authors:  Erich Knop; Nadja Knop; Thomas Millar; Hiroto Obata; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 5.  TFOS DEWS II pain and sensation report.

Authors:  Carlos Belmonte; Jason J Nichols; Stephanie M Cox; James A Brock; Carolyn G Begley; David A Bereiter; Darlene A Dartt; Anat Galor; Pedram Hamrah; Jason J Ivanusic; Deborah S Jacobs; Nancy A McNamara; Mark I Rosenblatt; Fiona Stapleton; James S Wolffsohn
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

6.  Neurotransmitter influence on human meibomian gland epithelial cells.

Authors:  Wendy R Kam; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-01       Impact factor: 4.799

7.  NADPH-diaphorase expression in the meibomian glands of rat palpebra in postnatal development.

Authors:  D Kluchova; A Bolekova; Ch Heichel; A J Bron; I Kozak
Journal:  Eur J Histochem       Date:  2010-11-23       Impact factor: 3.188

8.  Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm.

Authors:  Ren-Wen Ho; Po-Chiung Fang; Tsai-Ling Chao; Chun-Chih Chien; Ming-Tse Kuo
Journal:  Sci Rep       Date:  2018-05-30       Impact factor: 4.379

Review 9.  A Review of Periocular Botulinum Neurotoxin on the Tear Film Homeostasis and the Ocular Surface Change.

Authors:  Ren-Wen Ho; Po-Chiung Fang; Cheng-Hsien Chang; Yu-Peng Liu; Ming-Tse Kuo
Journal:  Toxins (Basel)       Date:  2019-01-24       Impact factor: 4.546

10.  Changes in ocular surface and Meibomian gland after penetrating Keratoplasty.

Authors:  Kang Yoon Kim; Byunghoon Chung; Eung Kweon Kim; Kyoung Yul Seo; Ikhyun Jun; Tae-Im Kim
Journal:  BMC Ophthalmol       Date:  2021-02-15       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.